Effect of Helicobacter pylori and Helminth Coinfection on the Immune Response to Mycobacterium tuberculosis
JA Bustamante-Rengifo, M Astudillo-Hernández… - Current …, 2021 - Springer
Tuberculosis remains one of the main causes of morbidity and mortality worldwide despite
decades of efforts to eradicate the disease. Although the immune response controls the …
decades of efforts to eradicate the disease. Although the immune response controls the …
[HTML][HTML] Point mutations in the glycosyltransferase domain of the pbp1a gene in amoxicillin-resistant Helicobacter pylori isolates
AJ Matta, DC Zambrano, YC Martínez… - … de Gastroenterología de …, 2023 - Elsevier
Introduction Helicobacter pylori (H. pylori) eradication treatment includes a proton pump
inhibitor and two antibiotics: amoxicillin and clarithromycin. The goal of that treatment is to …
inhibitor and two antibiotics: amoxicillin and clarithromycin. The goal of that treatment is to …
Epidemiology of Bacterial Resistance
PA Bradford - Antimicrobial Resistance in the 21st Century, 2018 - Springer
Bacterial pathogens have developed resistance to antibacterial agents through mutation
and acquisition of a panoply of resistance determinants. Outbreaks of resistant strains have …
and acquisition of a panoply of resistance determinants. Outbreaks of resistant strains have …
[HTML][HTML] Mutaciones puntuales en el dominio transglicosilasa del gen pbp1a en aislados de Helicobacter pylori resistentes a amoxicilina
AJ Matta, DC Zambrano, YC Martínez… - … de Gastroenterología de …, 2023 - Elsevier
Introducción El tratamiento para la erradicación de Helicobacter pylori (H. pylori) incluye un
inhibidor de la bomba de protones y 2 antibióticos: amoxicilina y claritromicina; este …
inhibidor de la bomba de protones y 2 antibióticos: amoxicilina y claritromicina; este …
Infection with Helicobacter pylori Presenting the vacA s2m2 haplotype is Strongly Associated with Protection Against Gastric Cancer
A Guevara-Tique, FC Valencia, JJS Olaya, RC Torres… - 2021 - researchsquare.com
Background: Infection with Helicobacter pylori is recognized as the main risk factor for
gastric cancer (GC); the clinical outcome of this infection is variable and partially depends on …
gastric cancer (GC); the clinical outcome of this infection is variable and partially depends on …
[PDF][PDF] REVISTA DE DE MEXICO
AJ Matta, DC Zambrano, YC Martínez, FF Fernández - 2022 - researchgate.net
Introduction: Helicobacter pylori (H. pylori) eradication treatment includes a proton pump
inhibitor and two antibiotics: amoxicillin and clarithromycin. The goal of that treatment is to …
inhibitor and two antibiotics: amoxicillin and clarithromycin. The goal of that treatment is to …
[引用][C] Variación de las tasas de resistencia antimicrobiana de Helicobacter pylori en el Eje cafetero
LJ Blandón Lozada, MC Galeano Cortes… - 2018 - Universidad Libre Seccional Pereira